Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer - Wikidata - wikimedia - TriplyDB

Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer

Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer

http://www.wikidata.org/entity/Q28574652

about

Targeting β-tubulin:CCT-β complexes incurs Hsp90- and VCP-related protein degradation and induces ER stress-associated apoptosis by triggering capacitative Ca2+ entry, mitochondrial perturbation and caspase overactivation.Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis.Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions.Withaferin A targets heat shock protein 90 in pancreatic cancer cells.Chronic hepatitis B in hepatocarcinogenesis HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells.Chromosome region maintenance 1 expression and its association with clinical pathological features in primary carcinoma of the liver.New insights on the role of epigenetic alterations in hepatocellular carcinoma.Targeting the oncogene and kinome chaperone CDC37.Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli.Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.Targeting GRP75 improves HSP90 inhibitor efficacy by enhancing p53-mediated apoptosis in hepatocellular carcinoma.Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.Human telomerase inhibitors from microbial source.Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts.Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice.Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma.Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response.Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma.An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.

P2860

88abfeb245302ca4c8db66bf34bfda49396a9a10

P248

Q30532061-4648AED3-0730-4DE7-A133-491ACF0DB2A4 Q30585904-4B1832DA-A464-4474-8987-36BE67505BCE Q33580269-2B13F75F-304D-45E3-81BB-F633DDFA1254 Q33855801-66E9342A-0F7B-4B69-9B22-B484CB827FD1 Q33966866-E68D643D-699E-411E-90E6-BAC16E7F4380 Q35004306-521825F8-656D-4D09-9053-D25DE92BDA61 Q36557635-04160B2A-E5B8-4935-834F-17CDBC400CE6 Q36956034-F9737452-9273-45BE-A2F1-88D9DD90F936 Q37002035-462FE9EF-1553-4675-9C19-E7C2A36CF36C Q37031728-046F93DE-08ED-4755-8422-641D6E5A0E0F Q37177064-1AE2DB43-CF3F-4EF5-B57F-94268A160FD6 Q37269298-C17415B6-33B2-45E5-AA0B-D6F65595F200 Q37293878-4A3F4DCB-856E-4449-8DF2-5308BB0B5296 Q37464190-98B560C6-8DBF-47C5-AFBD-939586B86664 Q37476446-6BDC00BE-5421-4E57-9C6D-57488077DDCB Q37490724-131E22BC-2373-4051-BCAF-52C93A59568E Q37580201-961F325B-59EC-4652-8C7A-2EA467C21E53 Q38541173-7C35837F-E45E-4D52-A54B-2349485F9763 Q38725015-563170DE-A1BA-48DC-88D1-7E6BD3AF73EF Q38913419-CEEF3A2D-63EA-4C49-8418-DC15D68EB1AA Q38972744-886BE8A5-2BBB-464D-99C7-035E9FBAA6B4 Q39561085-43018514-980F-44CD-94A9-3A0FED1EE0CA Q39904702-A8C46720-2F18-4248-BB3F-534AE264AD95 Q39968256-4130E7A2-55CC-41EC-9663-FD6F9265D8EE Q41918261-05BCC3DA-D3FF-4873-BA05-8DF659D32DB3 Q42202989-C529A307-E134-40A4-B4CA-C779AD460FD8 Q42616887-48F7C735-37F0-40B9-A7D1-66066F983C5A Q45227714-DF5A2883-1BD7-43E7-BD40-94D1EBB2E406 Q46012957-FB3392CD-5C93-4257-9749-044395AB12DA Q54318224-55261040-BD4D-42FC-A991-494B37BA84B0

P2860

Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer

http://www.wikidata.org/entity/Q28574652

description

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2005

@ast

im Dezember 2005 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2005/12/01)

@sk

vědecký článek publikovaný v roce 2005

@cs

wetenschappelijk artikel (gepubliceerd op 2005/12/01)

@nl

наукова стаття, опублікована в грудні 2005

@uk

مقالة علمية (نشرت في ديسمبر 2005)

@ar

name

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@ast

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@en

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@nl

type

label

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@ast

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@en

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@nl

prefLabel

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@ast

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@en

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@nl

P1433

Q28574652-2AC1BFDD-83EF-4F38-A37B-1A475A82FDC5

P1476

Q28574652-64AC98EF-875C-4C51-8CD9-90D237E34193

P2093

Q28574652-0D5A9401-F5D1-4F56-83E6-47B9D68B0F9A

Q28574652-167CE281-3BBD-49A9-8769-C6601D8DD097

Q28574652-27763C82-C31B-42BE-8D6A-EEDFCDBAD75C

Q28574652-28511D1B-ED4B-43FF-8622-EC9035DDB5A2

Q28574652-2FF31194-BC60-4B95-B794-0ABEC10682F6

Q28574652-32B69AAA-70A5-446C-90C5-DB2C32CE4B66

Q28574652-475A0E0C-E974-4826-BA9F-A4DD02C16CBC

Q28574652-7DD7A1A0-78E3-423F-B2EE-A041ED863203

Q28574652-8123CA0C-2B70-4FF8-BAB6-C718C6862FAB

Q28574652-8EE653E2-E6F8-4150-B1A3-EC214F65AC31

P2860

Q28574652-26159F54-23A5-4AD2-9507-2BE3FAA0DF21

Q28574652-E6F1F9E1-BAAD-4579-9AF3-B337FE2850F5

P304

Q28574652-83F7883C-8002-4BAC-9B49-1B46CA66DAC1

P31

Q28574652-0AC6D94A-EA14-45C3-AEEF-628587063D2A

P3181

Q28574652-7072A2D3-E13D-4AE3-B923-82E627DE14FA

P356

Q28574652-39F33850-5688-426D-909F-39D21E23E66D

P407

Q28574652-72417C70-5B5E-446B-8788-C90932389C53

P433

Q28574652-70E42F1F-A9C6-402F-A37B-F1B1E8CAC635

P478

Q28574652-D3C0EAEA-71D3-439F-A5B3-41416166F3A6

P577

Q28574652-CAA038ED-3083-4527-935E-B0A1613C06A0

P5875

Q28574652-46AF9EB2-37C8-4A62-B38A-44389F035021

P698

Q28574652-4293F4D4-225D-4719-83C6-02554D3E517D

P3181

P356

P1433

P1476

Role of HSP90, CDC37, and CRM1 ...... genesis and human liver cancer

@en

P2093

Diego F. Calvisi

http://www.w3.org/2001/XMLSchema#string

Francesco Feo

http://www.w3.org/2001/XMLSchema#string

Lucia Daino

http://www.w3.org/2001/XMLSchema#string

Maddalena Frau

http://www.w3.org/2001/XMLSchema#string

Maria A. Seddaiu

http://www.w3.org/2001/XMLSchema#string

Maria D. Muntoni

http://www.w3.org/2001/XMLSchema#string

Maria M. Simile

http://www.w3.org/2001/XMLSchema#string

Maria R. De Miglio

http://www.w3.org/2001/XMLSchema#string

Maria R. Muroni

http://www.w3.org/2001/XMLSchema#string

Rosa M. Pascale

http://www.w3.org/2001/XMLSchema#string

P2860

Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation.

P304

1310–1319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2187545

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.20962

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7450672

http://www.w3.org/2001/XMLSchema#string

P698

16317707

http://www.w3.org/2001/XMLSchema#string